Showing results (1-10 of 60) with videos related to
Sort By:
Pageof 6
European Journal of Medicinal Chemistry|November 1, 2025
Advances in the discovery of selective NaV1.8 inhibitors for pain managementZhixing Wu, Dai LuCell Stress & Chaperones|October 27, 2015
Controlled downregulation of the cannabinoid CB1 receptor provides a promising approach for the treatment of obesity and obesity-derived type 2 diabetesDai Lu, Rachel Dopart, Debra A KendallTetrahedron Letters|August 13, 2013
Synthesis and characterization of 2-substituted bornane pharmacophores for novel cannabinergic ligandsRichard I Duclos, Dai Lu, Jianxin Guo, et al.Future Science OA|November 13, 2018
Recent advances in the discovery of small-molecule inhibitors of HIV-1 integraseEungi Choi, Jayapal Reddy Mallareddy, Dai Lu, et al.Drug Metabolism Reviews|January 23, 2018
Allosteric modulators of cannabinoid receptor 1: developing compounds for improved specificityRachel Dopart, Dai Lu, Aron H Lichtman, et al.Food Chemistry|March 15, 2025
A simple post-processing approach induced Interface recombination to construct hollow cubic-shape Prussian blue analogs for biosensing and degradation of aflatoxins B1Tianyu Zhang, Dai Lu, Yini Zeng, et al.Acta Pharmacologica Sinica|October 19, 2018
Translational potential of allosteric modulators targeting the cannabinoid CB1 receptorDai Lu, Sri Sujana Immadi, Zhixing Wu, et al.Current Topics in Medicinal Chemistry|August 22, 2006
The cannabinergic system as a target for anti-inflammatory therapiesDai Lu, V Kiran Vemuri, Richard I Duclos, et al.Current Therapeutic Research, Clinical and Experimental|February 6, 2020
Structural Optimization of the Diarylurea PSNCBAM-1, an Allosteric Modulator of Cannabinoid Receptor 1Rachel Dopart, Sri Sujana Immadi, Dai Lu, et al.Talanta|December 11, 2020
Recent improvements in enzyme-linked immunosorbent assays based on nanomaterialsQian Zhao, Dai Lu, Guangyin Zhang, et al.Pageof 6